After failing to find a buyer at sheriff’s sale, the former Navy Yard home of pharmaceutical giant GSK has finally been sold.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The former home of ...
A building that once set a record for the most expensive Philadelphia office sale ever completed went up for auction this week and failed to attract even a minimum bid. In its 2018 heyday, the former ...
The Eastern Atlantic States Regional Council of Carpenters plans to relocate its headquarters and two local training centers ...
Contract development and manufacturing organization (CDMO) Samsung Biologics made a splash at the end of 2025, acquiring ...
GSK (LSE:GSK) has been drawing investor attention after recent share price moves and updated return figures, prompting a ...
The South Korean drug manufacturer reached an agreement to buy the two-building campus from GSK, which is also exiting an R&D facility in Rockville.
Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have gone elsewhere without tax incentives approved by local officials last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results